09:49 AM EST - Cynapsus Therapeutics Inc. : a specialty central nervous system pharmaceutical company focused on the treatment of OFF episodes in Parkinson's disease, is pleased to announce the grant of U.S. Patent No. 9,044,475, an additional patent in its sublingual apomorphine portfolio. Cynapsus Therapeutics Inc.
shares T.CTH are trading unchanged at $16.72.
